These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25551808)

  • 61. Matrix metalloproteinases in intracerebral hemorrhage.
    Xue M; Yong VW
    Neurol Res; 2008 Oct; 30(8):775-82. PubMed ID: 18826803
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat.
    Candelario-Jalil E; Taheri S; Yang Y; Sood R; Grossetete M; Estrada EY; Fiebich BL; Rosenberg GA
    J Pharmacol Exp Ther; 2007 Nov; 323(2):488-98. PubMed ID: 17704356
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage.
    Lee CZ; Xue Z; Zhu Y; Yang GY; Young WL
    Stroke; 2007 Sep; 38(9):2563-8. PubMed ID: 17673717
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
    Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6.
    Chen M; Li X; Zhang X; He X; Lai L; Liu Y; Zhu G; Li W; Li H; Fang Q; Wang Z; Duan C
    J Neuroinflammation; 2015 Apr; 12():61. PubMed ID: 25890011
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
    Frankowski JC; DeMars KM; Ahmad AS; Hawkins KE; Yang C; Leclerc JL; Doré S; Candelario-Jalil E
    Sci Rep; 2015 Dec; 5():17956. PubMed ID: 26648273
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards type-2 in experimental pulmonary tuberculosis in Balb/c mice.
    Hernandez-Pando R; Orozco H; Arriaga K; Pavön L; Rook G
    Int J Exp Pathol; 2000 Jun; 81(3):199-209. PubMed ID: 10971741
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.
    Liechti FD; Grandgirard D; Leppert D; Leib SL
    Infect Immun; 2014 Apr; 82(4):1710-8. PubMed ID: 24491581
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
    Wylie S; MacDonald IC; Varghese HJ; Schmidt EE; Morris VL; Groom AC; Chambers AF
    Clin Exp Metastasis; 1999 Mar; 17(2):111-7. PubMed ID: 10411102
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The meningococcal ABC-Type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice.
    Colicchio R; Ricci S; Lamberti F; Pagliarulo C; Pagliuca C; Braione V; Braccini T; Talà A; Montanaro D; Tripodi S; Cintorino M; Troncone G; Bucci C; Pozzi G; Bruni CB; Alifano P; Salvatore P
    Infect Immun; 2009 Sep; 77(9):3578-87. PubMed ID: 19528209
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of matrix metalloproteinases ameliorates blood-brain barrier disruption and neuropathological lesions caused by avirulent Semliki Forest virus infection.
    Keogh B; Sheahan BJ; Atkins GJ; Mills KH
    Vet Immunol Immunopathol; 2003 Aug; 94(3-4):185-90. PubMed ID: 12909414
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of a Peptide Construct on Differentiated Macrophage MMP-2 and MMP-9 Levels of Varicose Patients.
    Esfandiari G; Biranvand AS; Poursaleh A; Kakavandi N; Fattahi F; Ghasempour G; Bahraini E; Khosravi M; Najafi M
    Curr Pharm Des; 2019; 25(40):4303-4309. PubMed ID: 31663473
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer.
    Zervox EE; Franz MG; Salhab KF; Shafii AE; Menendez J; Gower WR; Rosemurgy AS
    J Gastrointest Surg; 2000; 4(6):614-9. PubMed ID: 11307097
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury.
    Abdul-Muneer PM; Pfister BJ; Haorah J; Chandra N
    Mol Neurobiol; 2016 Nov; 53(9):6106-6123. PubMed ID: 26541883
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sex-specific Association of Matrix Metalloproteinases with Secondary Injury and Outcomes after Intracerebral Hemorrhage.
    Howe MD; Furr JW; Zhu L; Edwards NJ; McCullough LD; Gonzales NR
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1718-1725. PubMed ID: 30922669
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mmp-9 inhibitors in the brain: can old bullets shoot new targets?
    Kaczmarek L
    Curr Pharm Des; 2013; 19(6):1085-9. PubMed ID: 23016686
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.
    Watson SA; Morris TM; Parsons SL; Steele RJ; Brown PD
    Br J Cancer; 1996 Nov; 74(9):1354-8. PubMed ID: 8912529
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases.
    Bissell MJ; Le Beyec J; Anderson RL
    J Natl Cancer Inst; 2002 Jan; 94(1):4-5. PubMed ID: 11773268
    [No Abstract]   [Full Text] [Related]  

  • 80. Log-scale dose response of inhibitors on a chip.
    Yun JY; Jambovane S; Kim SK; Cho SH; Duin EC; Hong JW
    Anal Chem; 2011 Aug; 83(16):6148-53. PubMed ID: 21696192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.